Samsung Medison and Bracco Imaging, represented by their CEOs, have endorsed an MoU at the European Congress of Radiology 2024, aiming to collaborate on advancing diagnostic ultrasound devices and contrast agents, focusing on research, development, market exploration, and potential applications in ultrasound-targeted contrast-enhanced drug delivery technologies.